Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)
- PMID: 11141143
- PMCID: PMC26599
- DOI: 10.1136/bmj.322.7277.15
Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)
Abstract
Objective: To examine the value of glycated haemoglobin (HbA(1c)) concentration, a marker of blood glucose concentration, as a predictor of death from cardiovascular and all causes in men.
Design: Prospective population study.
Setting: Norfolk cohort of European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk).
Subjects: 4662 men aged 45-79 years who had had glycated haemoglobin measured at the baseline survey in 1995-7 who were followed up to December 1999.
Main outcome measures: Mortality from all causes, cardiovascular disease, ischaemic heart disease, and other causes.
Results: Men with known diabetes had increased mortality from all causes, cardiovascular disease, and ischaemic disease (relative risks 2.2, 3.3, and 4.2, respectively, P <0.001 independent of age and other risk factors) compared with men without known diabetes. The increased risk of death among men with diabetes was largely explained by HbA(1c) concentration. HbA(1c) was continuously related to subsequent all cause, cardiovascular, and ischaemic heart disease mortality through the whole population distribution, with lowest rates in those with HbA(1c) concentrations below 5%. An increase of 1% in HbA(1c) was associated with a 28% (P<0.002) increase in risk of death independent of age, blood pressure, serum cholesterol, body mass index, and cigarette smoking habit; this effect remained (relative risk 1.46, P=0.05 adjusted for age and risk factors) after men with known diabetes, a HbA(1c) concentration >/=7%, or history of myocardial infarction or stroke were excluded. 18% of the population excess mortality risk associated with a HbA(1c) concentration >/=5% occurred in men with diabetes, but 82% occurred in men with concentrations of 5%-6.9% (the majority of the population).
Conclusions: Glycated haemoglobin concentration seems to explain most of the excess mortality risk of diabetes in men and to be a continuous risk factor through the whole population distribution. Preventive efforts need to consider not just those with established diabetes but whether it is possible to reduce the population distribution of HbA(1c) through behavioural means.
Comment in
-
"Normal" blood glucose and coronary risk.BMJ. 2001 Jan 6;322(7277):5-6. doi: 10.1136/bmj.322.7277.5. BMJ. 2001. PMID: 11141131 Free PMC article. No abstract available.
-
Glycated haemoglobin, diabetes, and mortality in men. Analytical information is required for generalisation of data.BMJ. 2001 Apr 21;322(7292):996-7. BMJ. 2001. PMID: 11339224 No abstract available.
-
Glycated haemoglobin, diabetes, and mortality in men. Maybe disturbance in physiological mechanisms regulating blood glucose is risk factor for cardiovascular death.BMJ. 2001 Apr 21;322(7292):996; author reply 996-7. BMJ. 2001. PMID: 11339225 Free PMC article. No abstract available.
-
Glycated haemoglobin, diabetes, and mortality in men. Medicine is now using diagnostic criteria rather than reference ranges.BMJ. 2001 Apr 21;322(7292):997. BMJ. 2001. PMID: 11339226 No abstract available.
References
-
- King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–1431. - PubMed
-
- Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997;14(suppl 5):S1–85. - PubMed
-
- American Diabetes Association. Screening for type 2 diabetes. Diabetes Care. 2000;23(suppl 1):S20–S23. - PubMed
-
- National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039–1057. - PubMed
-
- Report of a WHO Study Group. Diabetes mellitus. World Health Org Tech Rep Ser. 1985;727:9–17. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous